- Home
- RTC vs TLSI Comparison
RTC vs TLSI Comparison
Compare RTC & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RTC
- TLSI
- Stock Information
- Founded
- RTC 2003
- TLSI 2010
- Country
- RTC China
- TLSI United States
- Employees
- RTC N/A
- TLSI N/A
- Industry
- RTC Specialty Chemicals
- TLSI Medical Specialities
- Sector
- RTC Industrials
- TLSI Health Care
- Exchange
- RTC Nasdaq
- TLSI Nasdaq
- Market Cap
- RTC 171.1M
- TLSI 166.8M
- IPO Year
- RTC N/A
- TLSI N/A
- Fundamental
- Price
- RTC $7.86
- TLSI $4.83
- Analyst Decision
- RTC
- TLSI Strong Buy
- Analyst Count
- RTC 0
- TLSI 2
- Target Price
- RTC N/A
- TLSI $14.00
- AVG Volume (30 Days)
- RTC 14.5K
- TLSI 69.8K
- Earning Date
- RTC 01-01-0001
- TLSI 08-14-2024
- Dividend Yield
- RTC N/A
- TLSI N/A
- EPS Growth
- RTC N/A
- TLSI N/A
- EPS
- RTC N/A
- TLSI N/A
- Revenue
- RTC $71,896,698.00
- TLSI $24,736,000.00
- Revenue This Year
- RTC N/A
- TLSI $61.24
- Revenue Next Year
- RTC N/A
- TLSI $47.32
- P/E Ratio
- RTC N/A
- TLSI N/A
- Revenue Growth
- RTC N/A
- TLSI 67.75
- 52 Week Low
- RTC $2.48
- TLSI $3.32
- 52 Week High
- RTC $40.00
- TLSI $10.42
- Technical
- Relative Strength Index (RSI)
- RTC 51.37
- TLSI 36.52
- Support Level
- RTC $6.74
- TLSI $4.80
- Resistance Level
- RTC $7.39
- TLSI $5.32
- Average True Range (ATR)
- RTC 0.71
- TLSI 0.34
- MACD
- RTC -0.02
- TLSI -0.02
- Stochastic Oscillator
- RTC 63.29
- TLSI 3.06
About RTC Baijiayun Group Ltd.
Baijiayun Group Ltd is a ToB video cloud technology service provider that solves various pain points and needs in the field of video technology applications for enterprises. The group supplies energy for the digital development of enterprises through audio and video technology. The firm provides video technology solutions to enterprises and government agencies in various fields such as automobiles, finance, education, and medical care. Baijiayun has created three categories of product services namely video SaaS/PaaS business, video cloud products and software, and video system solutions. It has set up multiple R&D centers, branches, and offices across the country, enabling video technology to create industrial value and promote the development of the real economy.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.